News Releases

Targeting HIV: Moving closer to a potential cure

Tri-specific antibody targets and neutralizes 99.5% of HIV-1 virus strains

A team of researchers at IBBR, led by Dr. Yuxing Li, Associate Professor at the University of Maryland School of Medicine, Baltimore, and Principal Investigator at the Institute for Bioscience and Biotechnology Research (IBBR), Rockville, is showing how engineered multi-specific antibodies appear to be highly effective at preventing infection across a broad range of HIV-1 virus strains.

Dr. Gregory Payne and Team Nominated for the UMD Invention of the Year Award

The Division of Research has announced the nominees for the Invention of the Year Award.   For 2017, there were over 170 inventions disclosed and 52 patented, 46 technologies licensed, and the receipt of the largest investment in UMD history totaling $219.5 million from the A. James and Alice B. Clark Foundation. 

Expanding Partnership between University of Maryland and East China University of Science and Technology

UMD-ECUST Elevator Pitch competition hosted in Shanghai in January 2018.

The new year is off to a great start for the partnership between University of Maryland (UMD) and Shanghai’s East China University of Science and Technology (ECUST).  This partnership began five years ago when Prof.

IBBR Receives Grant to Explore Next Generation Multi-Specific Antibody Therapeutic: Next Step towards a Cure for HIV?

The goal is to develop and test a “first-in-class multi-specific antibody“, which could offer dramatic advantages over current treatments for AIDS patients, help eliminate hidden reservoirs of HIV, and potentially deliver on the promise of a long-awaited HIV cure.